Oxcarbazepine IP (300mg) & OXCARBZEN 300  Tablet : Dosage, Side Effects, Precautions and warnings.....

May 13, 2024

OXCARBZEN 300 

Oxcarbazepine IP (300mg)

Oxcarbzen 300, an innovative medication, is making waves in the field of neurology as a frontline treatment for various seizure disorders. In this detailed exploration, we delve into the intricacies of Oxcarbzen 300, shedding light on its mechanism of action, therapeutic applications, dosage regimen, potential side effects, and essential precautions.

Mechanism of Action: Oxcarbazepine IP (300mg) an antiepileptic drug, exerts its therapeutic effects primarily by blocking voltage-gated sodium channels, thus stabilizing neuronal membranes and inhibiting excessive electrical activity. By modulating sodium channel kinetics, Oxcarbzen 300 reduces the excitability of neurons, thereby suppressing seizure activity and preventing the spread of epileptic discharges.

Therapeutic Applications: Oxcarbzen 300 is indicated for the management of partial seizures in adults and children aged six years and above. Additionally, it may be prescribed as adjunctive therapy in the treatment of partial seizures refractory to other antiepileptic medications. Its efficacy in controlling seizure activity makes it a valuable option for individuals with epilepsy, improving seizure control and enhancing quality of life.

Dosage Regimen: The dosage of Oxcarbzen 300 should be individualized based on factors such as the patient's age, weight, renal function, and concomitant medications. Typically, the initial dose ranges from 300 to 600 mg daily, administered orally in divided doses. The dose may be titrated gradually based on the patient's response and tolerability, with maintenance doses ranging from 600 to 2400 mg per day.

Potential Side Effects: While Oxcarbzen 300 is generally well-tolerated, it may cause adverse effects in some individuals. Common side effects include dizziness, drowsiness, headache, nausea, vomiting, and fatigue. Additionally, some patients may experience hyponatremia, leukopenia, or rash. Serious but rare adverse reactions such as Stevens-Johnson syndrome or toxic epidermal necrolysis may occur, necessitating immediate medical attention.

Precautions: Several precautions should be observed while using Oxcarbzen 300. Patients should be monitored closely for signs of CNS depression, particularly when initiating therapy or during dose adjustments. Caution is advised in patients with a history of hypersensitivity reactions to carbamazepine or other antiepileptic drugs. Moreover, Oxcarbzen 300 may interact with certain medications, including oral contraceptives, leading to reduced contraceptive efficacy or breakthrough bleeding.

In conclusion Oxcarbzen 300 emerges as a valuable therapeutic option in the management of partial seizures, offering patients effective seizure control and improved quality of life. However, its use necessitates careful dosing, monitoring for potential side effects, and adherence to essential precautions. By harnessing the potential of Oxcarbzen 300 responsibly, healthcare providers can optimize treatment outcomes and empower individuals living with epilepsy to lead fulfilling lives. 

Steris Healthcare Pvt Ltd, founded by a group of expert professionals in the pharmaceutical industry in February 2018, operates as Sterispharma. This company, which is based in Navi Mumbai, holds certifications from WHO, GMP, and ISO. Its commitment is to provide high-quality drugs at affordable prices to its customers throughout India, following the rigorous guidelines set by the WHO. Steris offers the convenience of an online pharmacy where customers can easily buy medicines and enjoy the benefit of home delivery. At Steris, the mission is to supply a wide array of healthcare products designed to meet the varied needs of the medical community. Whether it is advanced treatments, medications for rare conditions, or basic health necessities, Sterispharma strives to serve the healthcare industry’s broad demands: gynecology, Pediatrics, Dental care, and Dermatology. The extensive product lineup from Steris includes treatments for various health areas such as Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.

 For further information: 

  EMAIL:  info@sterispharma.com  / contact@sterispharma.com   

 CALL/WHATSAPP: 7877551268, 7849827488

 BUY NOW

SHARE WITH